Aspects of Innovation and Leadership in Small and Medium Enterprises

Innovation is the characteristic function of the company's resources. A technologically efficient collaboration, with support from other partners, significantly develops and improves technological capabilities as well as product innovation performance. Both from a local and regional perspective, in knowledge-based economies, innovation is defined as a particularly important pillar. Logically, innovation is not feasible without a well-informed leader: If the latter is not anticipating new ideas and new implementation techniques to face the rapidly changing environment, subordinates will not certainly be. This raises the importance of leadership in the innovation process in SMEs. To ensure their competitiveness globally, SMEs must enjoy effective leadership which is unanimously regarded as a transformational one. Consequently, it is this type exactly that will be considered throughout this article. This paper uses secondary data sources to address the topic and its impact. It ends up by focusing on the importance of leadership in creating and communicating a clear vision toward adopting innovation as an important survival strategy in the long run

Occupational medicine type 2 diabetes screening in Luxembourg

peer reviewe

Screening for the risk on long-term sickness absence

Background: Long-term sickness absence is a growing concern in Belgium and other European countries. Since 2017, Belgian physicians of the sickness funding organisations are required to assess the re-integration possibilities within the first two months of sickness absence. Given the shortage of physicians in the assessment of work disability and the growing number of people in sickness absence, there is a need for a triage tool, allowing to assign return-to work support to patients having a high-risk profile not to resume work. Methods/design: The current study comprises a comprehensive validation process of a screening tool that supports Belgian physicians in guiding people back to work. The study consists of a theoretical construct validation (face validity and content validity), and an empirical construct validation (concurrence validity, factorial validity, predictive validity, hypothesis testing validity and known- group validity). Expected impact of the study for Public Health: The screening instrument assessing the risk for long-term sickness absence is a tool developed to support physicians who work for sickness funds and for occupational health and safety organisations. Both professionals play an important role in the return to work process and the prevention of long-term sickness absence. The screening tool aims at making a distinction between people who will resume their work independently and people who will need support to do so. Generation of this prediction model will help physicians to focus effort and resources in the high-risk group. Results may also help understand the relationship between the biopsychosocial model and long-term sick-leave

Infecția cu coronavirus de tip nou (COVID-19): protocol clinic național (ediția VIII) PCN-371

Acest protocol este elaborat și revizuit sistematic de grupul de lucru al Ministerului Sănătății al Republicii Moldova (MS), constituit din reprezentanți ai Comisiilor de specialitate ale MS, angajați ai Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” și Agenției Naționale pentru Sănătate Publică. Documentul nu este unul exhaustiv și se bazează pe recomandările actuale ale Organizației Mondiale a Sănătății privind infecția cu coronavirus de tip nou (COVID-19) și alte date disponibile la acest moment. Protocolul clinic național servește drept referință pentru elaborarea protocoalelor clinice instituționale, reieșind din posibilitățile reale ale fiecărei instituții medico-sanitare